Advertisement
Review Article|Articles in Press

Diagnostic and therapeutic strategies for vestibular neuritis of the Japan society for equilibrium research

Published:December 27, 2022DOI:https://doi.org/10.1016/j.anl.2022.12.005

      Abstract

      Objective

      To provide diagnostic and therapeutic strategies for vestibular neuritis in accordance with the Japanese Clinical Practice Guidelines for Vestibular Neuritis 2021.

      Methods

      The Committee for Clinical Practice Guidelines for Vestibular Neuritis was entrusted with a review of the relevant scientific literature on the above topic. Clinical Questions (CQs) concerning the treatment of vestibular neuritis were produced, and a search of the literature was conducted to identify studies related to the CQs. The recommendations were based on the literature review and the expert opinion of a subcommittee.

      Results

      We proposed the diagnostic criteria for vestibular neuritis, as well as answers to CQs, recommendations, and evidence levels for the treatment of vestibular neuritis.

      Conclusion

      The diagnostic criteria for vestibular neuritis were based on clinical history and examination findings after completing the differential diagnosis process. The treatment of vestibular neuritis was divided into acute, subacute, and chronic stages. The Japanese Clinical Practice Guidelines for Vestibular Neuritis 2021 should be used as a reference in the diagnosis and treatment of vestibular neuritis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Auris Nasus Larynx
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ikezono T.
        • Itoh A.
        • Takeda N.
        • Nakamura T.
        • Asai M.
        • Ikeda T.
        • et al.
        Documents for standards in diagnostic criteria for dizziness.
        Equilib Res. 2017; 76: 233-241
        • Fukui T.
        • Tango T.
        [Shinryougaidorain sakusei no tejyun version 4.3].
        EBM J. 2003; 4 ([in Japanese]): 284-292
        • Center MINDS
        Minds handbook for clinical practice guideline development.
        Igakushoin, Tokyo2014
        • Matsuo T.
        • Sekitani T.
        Vestibular neuronitis: neurotological findings and progress.
        ORL J Otorhinolaryngol Relat Spec. 1985; 47: 199-206
        • Mizuno M.
        • Katoh H.
        • Shimanuki T.
        • Mishima H.
        • Yoshioka K.
        • Itoh A.
        The clinical picture and course of vestibular neuronitis.
        Equilib Res. 2008; 67: 141-145
        • Kim H.A.
        • Hong J.H.
        • Lee H.
        • Yi H.A.
        • Lee S.R.
        • Lee S.Y.
        • et al.
        Otolith dysfunction in vestibular neuritis: recovery pattern and a predictor of symptom recovery.
        Neurology. 2008; 70: 449-453
        • Sekitani T.
        • Imate Y.
        • Noguchi T.
        • Inokuma T.
        Vestibular neuronitis: epidemiological survey by questionnaire in Japan.
        Acta Otolaryngol Suppl. 1993; 503: 9-12
        • Sekitani T.
        • Imate Y.
        Zenteishinkeien no shindan to keika.
        [Jibiinkouka toukeibugeka] MOOK. 1992; ([in Japanese]): 126-133
        • Choi K.D.
        • Oh S.Y.
        • Kim H.J.
        • Koo J.W.
        • Cho B.M.
        • Kim J.S.
        Recovery of vestibular imbalances after vestibular neuritis.
        Laryngoscope. 2007; 117: 1307-1312
        • Schmid-Priscoveanu A.
        • Böhmer A.
        • Obzina H.
        • Straumann D.
        Caloric and search-coil head-impulse testing in patients after vestibular neuritis.
        J Assoc Res Otolaryngol. 2001; 2: 72-78
        • Murofushi T.
        • Halmagyi G.M.
        • Yavor R.A.
        • Colebatch J.G.
        Absent vestibular evoked myogenic potentials in vestibular neurolabyrinthitis. An indicator of inferior vestibular nerve involvement?.
        Arch Otolaryngol Head Neck Surg. 1996; 122: 845-848
        • Lin C.M.
        • Young Y.H.
        Identifying the affected branches of vestibular nerve in vestibular neuritis.
        Acta Otolaryngol. 2011; 131: 921-928
        • Nagai N.
        • Ogawa Y.
        • Hagiwara A.
        • Otsuka K.
        • Inagaki T.
        • Shimizu S.
        • et al.
        Ocular vestibular evoked myogenic potentials induced by bone-conducted vibration in patients with unilateral inner ear disease.
        Acta Otolaryngol. 2014; 134: 151-158
        • Mandalà M.
        • Nuti D.
        • Broman A.T.
        • Zee D.S.
        Effectiveness of careful bedside examination in assessment, diagnosis, and prognosis of vestibular neuritis.
        Arch Otolaryngol Head Neck Surg. 2008; 134: 164-169
        • Aw S.T.
        • Fetter M.
        • Cremer P.D.
        • Karlberg M.
        • Halmagyi G.M.
        Individual semicircular canal function in superior and inferior vestibular neuritis.
        Neurology. 2001; 57: 768-774
        • Blödow A.
        • Pannasch S.
        • Walther L.E.
        Detection of isolated covert saccades with the video head impulse test in peripheral vestibular disorders.
        Auris Nasus Larynx. 2013; 40: 348-351
        • Mahringer A.
        • Rambold H.A.
        Caloric test and video-head-impulse: a study of vertigo/dizziness patients in a community hospital.
        Eur Arch Otorhinolaryngol. 2014; 271: 463-472
        • Böhmer A.
        • Rickenmann J.
        The subjective visual vertical as a clinical parameter of vestibular function in peripheral vestibular diseases.
        J Vestib Res. 1995; 5: 35-45
        • Ogawa Y.
        • Otsuka K.
        • Shimizu S.
        • Inagaki T.
        • Kondo T.
        • Suzuki M.
        Subjective visual vertical perception in patients with vestibular neuritis and sudden sensorineural hearing loss.
        J Vestib Res. 2012; 22: 205-211
        • Kunihiro T.
        Subjective visual vertical (SVV).
        Equilib Res. 2004; 63: 533-548
        • Sekitani T.
        Current Data on vestibular neuronitis.
        Pract Otol. 1988; 81 (Kyoto): 637-647
        • Strupp M.
        • Jäger L.
        • Müller-Lisse U.
        • Arbusow V.
        • Reiser M.
        • Brandt T.
        High resolution Gd-DTPA MR imaging of the inner ear in 60 patients with idiopathic vestibular neuritis: no evidence for contrast enhancement of the labyrinth or vestibular nerve.
        J Vestib Res. 1998; 8: 427-433
        • Karlberg M.
        • Annertz M.
        • Magnusson M.
        Acute vestibular neuritis visualized by 3-T magnetic resonance imaging with high-dose gadolinium.
        Arch Otolaryngol Head Neck Surg. 2004; 130: 229-232
        • Hashimoto M.
        • Yamashita H.
        [Zenteishinkeien no byotai, shindan, chiryo].
        Med Pract. 2020; 37 ([in Japanese]): 561-564
        • McDonnell M.N.
        • Hillier S.L.
        Vestibular rehabilitation for unilateral peripheral vestibular dysfunction.
        Cochrane Database Syst Rev. 2015; 1Cd005397
        • Nomura S.
        Recently introduced anti-dizziness/vertigo drugs in Japan.
        Equilib Res. 2019; 78: 7-15
        • Kitahara T.
        • Takeda N.
        • Nishiike S.
        • Uno A.
        • Fukushima M.
        • Okuura S.
        • et al.
        Effects of steroid therapy on long-term canal prognosis and activity in the daily life of vestibular neuronitis patient.
        J Otolaryngol Jpn. 2001; 104: 1059-1064
        • Nihonjibiinkoukagakkai
        [Toppatsuseinanchou, ganmenshinkeimahitou no suteroidochiryou ni okeru Bgatakanen uirusu saikasseikaboushi ni kannsuru shishin].
        J Otolaryngol Jpn. 2019; 122 ([in Japanese]): 1551
        • Koizuka I.
        Evidence and neural mechanism of vestibular rehabilitation.
        Equilib Res. 2018; 77: 288-297
        • Strupp M.
        • Arbusow V.
        • Maag K.P.
        • Gall C.
        • Brandt T.
        Vestibular exercises improve central vestibulospinal compensation after vestibular neuritis.
        Neurology. 1998; 51: 838-844
        • Nakajima S.
        • Umeki S.
        A follow-up study of the prognosis of the vestibular neuronitis in 17 patients.
        Equilib Res. 1981; 40: 251-256
        • Imate Y.
        • Sekitani T.
        • Yamashita H.
        • Okami K.
        Epidemiological survey of vestibular neuronitis.
        Equilib Res. 1992; : 15-19
        • Okinaka Y.
        • Sekitani T.
        • Okazaki H.
        • Miura M.
        • Tahara T.
        Progress of caloric response of vestibular neuronitis.
        Acta Otolaryngol Suppl. 1993; 503: 18-22
        • Takeda T.
        • Koizuka I.
        • Kohno M.
        • Nishiike S.
        • Kubo T.
        • Ogino H.
        Diagnostic and therapeutic problems in vestibular neuronitis: clinical implications for sudden vertigo.
        J Otolaryngol Jpn. 1995; 98: 951-958
        • Kitahara T.
        [Zenteishinkeien].
        Rinshoutokenkyu. 2018; 95 ([in Japanese]): 735-739
        • Iwasaki S.
        Vestibular neuritis: diagnosis and treatment.
        Jikoutoukei. 2017; 89: 48-54
        • Ochiai A.
        • Naganuma H.
        Kitasato method of rehabilitation for persistent dysequilibrium and its evaluation.
        Equilib Res. 2019; 78: 16-22
        • Ito T.
        • Shiozaki T.
        • Wada Y.
        • Fujita N.
        • Yamanaka T.
        • Kitahara T.
        Vestibular rehabilitation at Nara Medical University -MAHOROBA.
        Equilib Res. 2018; 77: 549-556
        • Koizuka I.
        [Memai rihabiriteshon].
        J Otolaryngol Jpn. 2013; 116 ([in Japanese]): 147-153
        • Nauta J.J.
        Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo.
        Eur Arch Otorhinolaryngol. 2014; 271: 887-897
        • Della Pepa C.
        • Guidetti G.
        • Eandi M
        Betahistine in the treatment of vertiginous syndromes: a meta-analysis.
        Acta Otorhinolaryngol Ital. 2006; 26: 208-215
        • Ramos Alcocer R.
        • Ledezma Rodríguez J.G.
        • Navas Romero A.
        • Cardenas Nuñez J.L.
        • Rodríguez Montoya V.
        • Deschamps J.J.
        • et al.
        Use of betahistine in the treatment of peripheral vertigo.
        Acta Otolaryngol. 2015; 135: 1205-1211
        • Amini A.
        • Heidari K.
        • Kariman H.
        • Taghizadeh M.
        • Hatamabadi H.
        • Shahrami A.
        • et al.
        Histamine antagonists for treatment of peripheral vertigo: a meta-analysis.
        J Int Adv Otol. 2015; 11: 138-142
        • Scholtz A.W.
        • Steindl R.
        • Burchardi N.
        • Bognar-Steinberg I.
        • Baumann W.
        Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study.
        Clin Drug Investig. 2012; 32: 387-399
        • Marill K.A.
        • Walsh M.J.
        • Nelson B.K.
        Intravenous lorazepam versus dimenhydrinate for treatment of vertigo in the emergency department: a randomized clinical trial.
        Ann Emerg Med. 2000; 36: 310-319
        • Irving C.
        • Richman P.
        • Kaiafas C.
        • Eskin B.
        • Allegra J
        Intramuscular droperidol versus intramuscular dimenhydrinate for the treatment of acute peripheral vertigo in the emergency department: a randomized clinical trial.
        Acad Emerg Med. 2002; 9: 650-653
        • Spinks A.
        • Wasiak J.
        Scopolamine (hyoscine) for preventing and treating motion sickness.
        Cochrane Database Syst Rev. 2011; CD002851
        • Pyykkö I.
        • Schalen L.
        • Jantti V.
        Transdermally administered scopolamine vs. dimenhydrinate. I. Effect on nausea and vertigo in experimentally induced motion sickness.
        Acta Otolaryngol. 1985; 99: 588-596
        • Kohl R.L.
        • Homick J.L.
        • Cintron N.
        • Calkins D.S.
        Lack of effects of astemizole on vestibular ocular reflex, motion sickness, and cognitive performance in man.
        Aviat Space Environ Med. 1987; 58: 1171-1174
        • Oosterveld W.J.
        The combined effect of cinnarizine and domperidone on vestibular susceptibility.
        Aviat Space Environ Med. 1987; 58: 218-223
        • Small M.D.
        Diphenidol, a new antiemetic: a double-blind, placebo-controlled study.
        Am J Dig Dis. 1966; 11: 648-651
        • Goudakos J.K.
        • Markou K.D.
        • Franco-Vidal V.
        • Vital V.
        • Tsaligopoulos M.
        • Darrouzet V.
        Corticosteroids in the treatment of vestibular neuritis: a systematic review and meta-analysis.
        Otol Neurotol. 2010; 31: 183-189
        • Fishman J.M.
        • Burgess C.
        • Waddell A.
        Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis).
        Cochrane Database Syst Rev. 2011; CD008607
        • Adamec I.
        • Krbot Skorić M.
        • Gabelić T.
        • Barun B.
        • Ljevak J.
        • Bujan Kovač A.
        • et al.
        Intravenous dexamethasone in acute management of vestibular neuritis: a randomized, placebo-controlled, single-blind trial.
        Eur J Emerg Med. 2016; 23: 363-369
        • Strupp M.
        • Zingler V.C.
        • Arbusow V.
        • Niklas D.
        • Maag K.P.
        • Dieterich M.
        • et al.
        Methylprednisolone, valacyclovir, or the combination for vestibular neuritis.
        N Engl J Med. 2004; 351: 354-361
        • Kitahara T.
        • Kondoh K.
        • Morihana T.
        • Okumura S.I.
        • Horii A.
        • Takeda N.
        • et al.
        Steroid effects on vestibular compensation in human.
        Neurol Res. 2003; 25: 287-291
        • Murdin L.
        • Hussain K.
        • Schilder A.G.
        Betahistine for symptoms of vertigo.
        Cochrane Database Syst Rev. 2016; Cd010696
        • Watanabe I.
        • Okubo J.
        • Oku T.
        • Mizukoshi K.
        • Watanabe Y.
        • Matsunaga T.
        • et al.
        A double-blind controlled study on the antivertiginous dose effects of ATP in patients with vertigo and/or dizziness.
        Pract Otol. 1982; 75 (Kyoto): 393-415
        • Arnold S.A.
        • Stewart A.M.
        • Moor H.M.
        • Karl R.C.
        • Reneker J.C.
        The effectiveness of vestibular rehabilitation interventions in treating unilateral peripheral vestibular disorders: a systematic review.
        Physiother Res Int. 2017; 22: e1635